EDITORIAL |
|
*
E.M. Tareev and his nephrtitis doctrine (on 115-th anniversary birthday anniversary of E.M. Tareev)
|
4-6 |
|
*
Low birth weight as a risk factor for chronic kidney disease
|
7-12 |
|
*
Angiotension II blockers: when to use them in the beginning of antihypertensive therapy?
|
13-18 |
HOTLINE TOPIC |
|
A.V. Smirnov, V.A. Dobronravov, I.G. Kaukov
Ways of modernization of chronic kidney disease classification
|
19-23 |
|
N.A. Moukhin
Chronic kidney disease in women
|
24-28 |
SOCIAL ASPECTS OF NEPROLOGY |
|
E.M. Shilov, N.L. Kozlovskaya, I.N. Bobkova, M.Yu. Shvetsov, A.V. Vatazin
Chronic kidney disease and program of increase of life span in Russian Federation
|
29-38 |
STATE-OF-ART |
|
G.P. Arutiunov, L.G. Oganezova
Acute myocardial infarction and kidney function
|
39-44 |
ORIGINAL PAPERS |
|
O.V. Maslova, Yu.I. Suntsov, M.V. Shestakova, I.V. Kazakova, О.K. Vikulova, O.Yu. Sukhareva, S.A. Martynov
Prevalence of diabetic nephropathy and chronic kidney disease in diabetes mellitus in Russian Federation
|
45-50 |
|
N.V. Tchebotareva, I.N. Bobkova, L.V. Kozlovskaya, V.A. Varshavskii, E.P. Golytsina
Monocyte chemoattractant protein-1 and transforming growth factor-beta1 urinary excretion as a marker of renal fibrosis in chronic glomerulonephritis
|
51-55 |
PHARMACOTHERAPY |
|
L.V. Kozlovskaya
Chronic glomerulonephritis: arguments for cyclosporine use
|
56-61 |
EPIDEMIOLOGY AND PREVENTION |
|
T.E. Rudenko, I.M. Kutyrina
Obesity as a factor of vascular remodeling
|
62-67 |
CLINICAL PRACTICE EXPERIENCE |
|
L.V. Ivanitskii, T.N. Krasnova, T.N. Lopatkina, M.D. Romanova
Renal masks of Sjogren disease
|
68-71 |
|
E.V. Voloshinova, E.V. Grigorieva, S.I. Sajnova, A.P. Rebrov
Clinical variants of systemic amyloidosis with myocardial involvement and difficulties of its diagnosis
|
72-75 |
CLASSICS IN NEPHROLOGY |
|
D.A.K. Black
Estimation of treatment methods in nephrology
|
76-77 |
EPONYM |
|
*
Bright disease
|
78-79 |
Русский
